Key Corporations Dominating Vietnam Amlodipine Besylate Market | Market Insights 2026

Key Corporations Dominating the Vietnam Amlodipine Besylate Market

The Vietnam Amlodipine Besylate Market is shaped by a combination of international pharmaceutical giants and local manufacturers, each vying for market share with a focus on product quality and innovation. Key players in the market include Pfizer Inc., Novartis AG, Viatris Inc., Dr Reddy's Laboratories Ltd., and Zydus Lifesciences Limited.

Vietnam Amlodipine Besylate Market Overview

According to 6Wresearch, the Vietnam Amlodipine Besylate Market is growing, and the major factor for this growth is the increasing number of people suffering from hypertension and other heart problems. Amlodipine Besylate is a calcium channel blocker and is used for the treatment of high blood pressure and angina.

The increasing demand for effective and cost-efficient treatment for the above problems and the increasing demand for generic drugs are the major factors for the growth of the market. In addition, the focus on healthcare and the government's initiatives for the production of generic drugs are also increasing the growth of the market. Also, the demand for the drug is increasing because of the presence of major players in the market.

Competitive Landscape

The competitive environment in the Vietnam Amlodipine Besylate market is characterized by the presence of several multinational corporations and local pharmaceutical companies. The major companies use their good distribution network and strong production capabilities to maintain their competitive advantage in the market. Research and development is another important factor in this market as companies seek to launch cost-effective products in the market.

Here is a compilation of key players active in the Vietnam Amlodipine Besylate Market:

1. Pfizer Inc.

Pfizer is a global pharmaceutical leader, originating Norvasc, a widely prescribed Amlodipine Besylate product for hypertension.

2. Novartis AG

Novartis manufactures Exforge and Normodipine, offering effective hypertension treatments in the Vietnam market.

3. Viatris Inc.

Viatris, including Mylan Laboratories, is a leading importer of generic Amlodipine Besylate products in Vietnam.

4. Dr. Reddy's Laboratories Ltd.

Dr. Reddy's is a major supplier of APIs and generics, contributing significantly to the availability of Amlodipine Besylate in Vietnam.

5. Zydus Lifesciences Limited

Zydus Lifesciences offers Amlodac, a leading Amlodipine Besylate generic, in the Vietnamese market.

6. Cipla Ltd.

Cipla provides Amlopres, a trusted Amlodipine Besylate formulation used widely in the treatment of hypertension.

7. Pymepharco Joint Stock Company

Pymepharco is a leading local manufacturer of Amlodipine Besylate and other pharmaceuticals in Vietnam.

8. DHG Pharmaceutical Joint Stock Company

DHG Pharmaceutical is a key local player, providing high-quality generic Amlodipine Besylate to the Vietnamese market.

9. Imexpharm Corporation

Imexpharm is a significant producer of generics, including Amlodipine Besylate, for the Vietnamese market.

10. Traphaco Joint Stock Company

Traphaco is a leading pharmaceutical company in Vietnam, manufacturing Amlodipine Besylate and other generic drugs.

11. Hetero Drugs Limited

Hetero Drugs is a major supplier of APIs and generics, including Amlodipine Besylate, for the Vietnamese market.

Key Corporations Dominating Vietnam Amlodipine Besylate Market 2026 : FAQs